Systematic analysis of natural antibody responses to P. falciparum merozoite antigens by protein arrays

Journal of Proteomics

Volumn 78, Issue , 2013, Pages 148-158

  Fan, Yan Ting ^a   Wang, Yue ^b   Ju, Chuan ^a   Zhang, Ting ^a   Xu, Bin ^a   Hu, Wei ^a   Chen, Jun Hu ^a  

^a BEIJING HOSPITAL   (China)

^b INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Antibody response; Antigen; Merozoite; Plasmodium falciparum; Protein array

Indexed keywords

ETRAMP11.2 PROTEIN; ETRAMP14.1 PROTEIN; MEROZOITE ANTIGEN; MEROZOITE SURFACE PROTEIN 1; MEROZOITE SURFACE PROTEIN 2; MEROZOITE SURFACE PROTEIN 3.5; PARASITE ANTIGEN; RALP1 PROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANTIBODY RESPONSE; ARTICLE; CELL FREE SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MEROZOITE; MOLECULAR CLONING; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN MICROARRAY; SCREENING; WESTERN BLOTTING; WHEAT GERM CELL FREE SYSTEM;

ADOLESCENT; ADULT; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; FEMALE; HUMANS; MALARIA, FALCIPARUM; MALE; MEROZOITES; MIDDLE AGED; PLASMODIUM FALCIPARUM; PROTEIN ARRAY ANALYSIS;

PLASMODIUM FALCIPARUM; TRITICUM AESTIVUM;

EID: 84871739684     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2012.11.020     Document Type: Article

References (60)

1. Murray C.J., Rosenfeld L.C., Lim S.S., Andrews K.G., Foreman K.J., Haring D., et al. Global malaria mortality between 1980 and 2010: a systematic analysis. Lancet 2012, 379:413-431.
2. Beeson J.G., Osier F.H., Engwerda C.R. Recent insights into humoral and cellular immune responses against malaria. Trends Parasitol 2008, 24:578-584.
3. Fowkes F.J., Richards J.S., Simpson J.A., Beeson J.G. The relationship between anti-merozoite antibodies and incidence of Plasmodium falciparum malaria: a systematic review and meta-analysis. PLoS Med 2009, 7:e1000218.
4. Persson K.E., McCallum F.J., Reiling L., Lister N.A., Stubbs J., Cowman A.F., et al. Variation in use of erythrocyte invasion pathways by Plasmodium falciparum mediates evasion of human inhibitory antibodies. J Clin Invest 2008, 118:342-351.
5. Crabb B.S., Beeson J.G. Promising functional readouts of immunity in a blood-stage malaria vaccine trial. PLoS Med 2005, 2:e380.
6. Cowman A.F., Crabb B.S. Invasion of red blood cells by malaria parasites. Cell 2006, 124:755-766.
7. Rodriguez L.E., Curtidor H., Urquiza M., Cifuentes G., Reyes C., Patarroyo M.E. Intimate molecular interactions of P. falciparum merozoite proteins involved in invasion of red blood cells and their implications for vaccine design. Chem Rev 2008, 108:3656-3705.
8. Boyle M.J., Richards J.S., Gilson P.R., Chai W., Beeson J.G. Interactions with heparin-like molecules during erythrocyte invasion by Plasmodium falciparum merozoites. Blood 2010, 115:4559-4568.
9. Srinivasan P., Beatty W.L., Diouf A., Herrera R., Ambroggio X., Moch J.K., et al. Binding of Plasmodium merozoite proteins RON2 and AMA1 triggers commitment to invasion. Proc Natl Acad Sci U S A 2011, 108:13275-13280.
10. Baum J., Maier A.G., Good R.T., Simpson K.M., Cowman A.F. Invasion by P. falciparum merozoites suggests a hierarchy of molecular interactions. PLoS Pathog 2005, 1:e37.
11. Mayer D.C., Cofie J., Jiang L., Hartl D.L., Tracy E., Kabat J., et al. Glycophorin B is the erythrocyte receptor of Plasmodium falciparum erythrocyte-binding ligand, EBL-1. Proc Natl Acad Sci U S A 2009, 106:5348-5352.
12. Tham W.H., Wilson D.W., Lopaticki S., Schmidt C.Q., Tetteh-Quarcoo P.B., Barlow P.N., et al. Complement receptor 1 is the host erythrocyte receptor for Plasmodium falciparum PfRh4 invasion ligand. Proc Natl Acad Sci U S A 2010, 107:17327-17332.
13. Crosnier C., Bustamante L.Y., Bartholdson S.J., Bei A.K., Theron M., Uchikawa M., et al. Basigin is a receptor essential for erythrocyte invasion by Plasmodium falciparum. Nature 2011, 480:534-537.
14. Sanders P.R., Gilson P.R., Cantin G.T., Greenbaum D.C., Nebl T., Carucci D.J., et al. Distinct protein classes including novel merozoite surface antigens in Raft-like membranes of Plasmodium falciparum. J Biol Chem 2005, 280:40169-40176.
15. Gilson P.R., Nebl T., Vukcevic D., Moritz R.L., Sargeant T., Speed T.P., et al. Identification and stoichiometry of glycosylphosphatidylinositol-anchored membrane proteins of the human malaria parasite Plasmodium falciparum. Mol Cell Proteomics 2006, 5:1286-1299.
16. Doolan D.L. Plasmodium immunomics. Int J Parasitol 2011, 41:3-20.
17. Trieu A., Kayala M.A., Burk C., Molina D.M., Freilich D.A., Richie T.L., et al. Sterile protective immunity to malaria is associated with a panel of novel P. falciparum antigens. Mol Cell Proteomics 2011, 10. [M111 007948].
18. Gardner M.J., Hall N., Fung E., White O., Berriman M., Hyman R.W., et al. Genome sequence of the human malaria parasite Plasmodium falciparum. Nature 2002, 419:498-511.
19. Florens L., Washburn M.P., Raine J.D., Anthony R.M., Grainger M., Haynes J.D., et al. A proteomic view of the Plasmodium falciparum life cycle. Nature 2002, 419:520-526.
20. Bozdech Z., Llinas M., Pulliam B.L., Wong E.D., Zhu J., DeRisi J.L. The transcriptome of the intraerythrocytic developmental cycle of Plasmodium falciparum. PLoS Biol 2003, 1:E5.
21. Winzeler E.A. Malaria research in the post-genomic era. Nature 2008, 455:751-756.
22. Hu G., Cabrera A., Kono M., Mok S., Chaal B.K., Haase S., et al. Transcriptional profiling of growth perturbations of the human malaria parasite Plasmodium falciparum. Nat Biotechnol 2010, 28:91-98.
23. Chen J.H., Jung J.W., Wang Y., Ha K.S., Lu F., Lim C.S., et al. Immunoproteomics profiling of blood stage Plasmodium vivax infection by high-throughput screening assays. J Proteome Res 2010, 9:6479-6489.
24. Zhou S.S., Wang Y., Li Y. Malaria situation in the People's Republic of China in 2010. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 2011, 29:401-403.
25. Shi W.Q., Zhou X.J., Zhang Y., Zhou X.N., Hu L., Wang X.Z., et al. An investigation on malaria vectors in western part of China-Myanmar border. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 2011, 29:134-137.
26. Aurrecoechea C., Brestelli J., Brunk B.P., Dommer J., Fischer S., Gajria B., et al. PlasmoDB: a functional genomic database for malaria parasites. Nucleic Acids Res 2009, 37:D539-D543.
27. Petersen T.N., Brunak S., von Heijne G., Nielsen H. SignalP 4.0: discriminating signal peptides from transmembrane regions. Nat Methods 2011, 8:785-786.
28. Eisenhaber B., Bork P., Eisenhaber F. Prediction of potential GPI-modification sites in proprotein sequences. J Mol Biol 1999, 292:741-758.
29. Tsuboi T., Takeo S., Iriko H., Jin L., Tsuchimochi M., Matsuda S., et al. Wheat germ cell-free system-based production of malaria proteins for discovery of novel vaccine candidates. Infect Immun 2008, 76:1702-1708.
30. Chen J.H., Wang Y., Ha K.S., Lu F., Suh I.B., Lim C.S., et al. Measurement of naturally acquired humoral immune responses against the C-terminal region of the Plasmodium vivax MSP1 protein using protein arrays. Parasitol Res 2011, 109:1259-1266.
31. Crompton P.D., Kayala M.A., Traore B., Kayentao K., Ongoiba A., Weiss G.E., et al. A prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarray. Proc Natl Acad Sci U S A 2010, 107:6958-6963.
32. Saeed A.I., Sharov V., White J., Li J., Liang W., Bhagabati N., et al. TM4: a free, open-source system for microarray data management and analysis. Biotechniques 2003, 34:374-378.
33. Goshima N., Kawamura Y., Fukumoto A., Miura A., Honma R., Satoh R., et al. Human protein factory for converting the transcriptome into an in vitro-expressed proteome. Nat Methods 2008, 5:1011-1017.
34. Wickramarachchi T., Devi Y.S., Mohmmed A., Chauhan V.S. Identification and characterization of a novel Plasmodium falciparum merozoite apical protein involved in erythrocyte binding and invasion. PLoS One 2008, 3:e1732.
35. Haase S., Cabrera A., Langer C., Treeck M., Struck N., Herrmann S., et al. Characterization of a conserved rhoptry-associated leucine zipper-like protein in the malaria parasite Plasmodium falciparum. Infect Immun 2008, 76:879-887.
36. Singh S., Soe S., Weisman S., Barnwell J.W., Perignon J.L., Druilhe P. A conserved multi-gene family induces cross-reactive antibodies effective in defense against Plasmodium falciparum. PLoS One 2009, 4:e5410.
37. Sirima S.B., Cousens S., Druilhe P. Protection against malaria by MSP3 candidate vaccine. N Engl J Med 2011, 365:1062-1064.
38. Spielmann T., Fergusen D.J., Beck H.P. etramps, a new Plasmodium falciparum gene family coding for developmentally regulated and highly charged membrane proteins located at the parasite-host cell interface. Mol Biol Cell 2003, 14:1529-1544.
39. Doolan D.L., Mu Y., Unal B., Sundaresh S., Hirst S., Valdez C., et al. Profiling humoral immune responses to P. falciparum infection with protein microarrays. Proteomics 2008, 8:4680-4694.
40. Aguiar J.C., LaBaer J., Blair P.L., Shamailova V.Y., Koundinya M., Russell J.A., et al. High-throughput generation of P. falciparum functional molecules by recombinational cloning. Genome Res 2004, 14:2076-2082.
41. VanBuskirk K.M., O'Neill M.T., De La Vega P., Maier A.G., Krzych U., Williams J., et al. Preerythrocytic, live-attenuated Plasmodium falciparum vaccine candidates by design. Proc Natl Acad Sci U S A 2009, 106:13004-13009.
42. Sundaresh S., Doolan D.L., Hirst S., Mu Y., Unal B., Davies D.H., et al. Identification of humoral immune responses in protein microarrays using DNA microarray data analysis techniques. Bioinformatics 2006, 22:1760-1766.
43. Collins C.R., Withers-Martinez C., Hackett F., Blackman M.J. An inhibitory antibody blocks interactions between components of the malarial invasion machinery. PLoS Pathog 2009, 5:e1000273.
44. Tonkin M.L., Roques M., Lamarque M.H., Pugniere M., Douguet D., Crawford J., et al. Host cell invasion by apicomplexan parasites: insights from the co-structure of AMA1 with a RON2 peptide. Science 2011, 333:463-467.
45. Thera M.A., Doumbo O.K., Coulibaly D., Laurens M.B., Ouattara A., Kone A.K., et al. A field trial to assess a blood-stage malaria vaccine. N Engl J Med 2011, 365:1004-1013.
46. Takala S.L., Coulibaly D., Thera M.A., Dicko A., Smith D.L., Guindo A.B., et al. Dynamics of polymorphism in a malaria vaccine antigen at a vaccine-testing site in Mali. PLoS Med 2007, 4:e93.
47. Sutherland C. A challenge for the development of malaria vaccines: polymorphic target antigens. PLoS Med 2007, 4:e116.
48. Druilhe P., Spertini F., Soesoe D., Corradin G., Mejia P., Singh S., et al. A malaria vaccine that elicits in humans antibodies able to kill Plasmodium falciparum. PLoS Med 2005, 2:e344.
49. Roussilhon C., Oeuvray C., Muller-Graf C., Tall A., Rogier C., Trape J.F., et al. Long-term clinical protection from falciparum malaria is strongly associated with IgG3 antibodies to merozoite surface protein 3. PLoS Med 2007, 4:e320.
50. Richards J.S., Stanisic D.I., Fowkes F.J., Tavul L., Dabod E., Thompson J.K., et al. Association between naturally acquired antibodies to erythrocyte-binding antigens of Plasmodium falciparum and protection from malaria and high-density parasitemia. Clin Infect Dis 2010, 51:e50-e60.
51. Reiling L., Richards J.S., Fowkes F.J., Barry A.E., Triglia T., Chokejindachai W., et al. Evidence that the erythrocyte invasion ligand PfRh2 is a target of protective immunity against Plasmodium falciparum malaria. J Immunol 2010, 185:6157-6167.
52. Wickramarachchi T., Cabrera A.L., Sinha D., Dhawan S., Chandran T., Devi Y.S., et al. A novel Plasmodium falciparum erythrocyte binding protein associated with the merozoite surface, PfDBLMSP. Int J Parasitol 2009, 39:763-773.
53. Sakamoto H., Takeo S., Maier A.G., Sattabongkot J., Cowman A.F., Tsuboi T. Antibodies against a Plasmodium falciparum antigen PfMSPDBL1 inhibit merozoite invasion into human erythrocytes. Vaccine 2012, 30:1972-1980.
54. Hodder A.N., Czabotar P.E., Uboldi A.D., Clarke O.B., Lin C.S., Healer J., et al. Insights into duffy binding-like domains through the crystal structure and function of the merozoite surface protein MSPDBL2 from Plasmodium falciparum. J Biol Chem 2012, 287:32922-32939.
55. Tetteh K.K., Stewart L.B., Ochola L.I., Amambua-Ngwa A., Thomas A.W., Marsh K., et al. Prospective identification of malaria parasite genes under balancing selection. PLoS One 2009, 4:e5568.
56. Ochola L.I., Tetteh K.K., Stewart L.B., Riitho V., Marsh K., Conway D.J. Allele frequency-based and polymorphism-versus-divergence indices of balancing selection in a new filtered set of polymorphic genes in Plasmodium falciparum. Mol Biol Evol 2010, 27:2344-2351.
57. Arumugam T.U., Takeo S., Yamasaki T., Thonkukiatkul A., Miura K., Otsuki H., et al. Discovery of GAMA, a Plasmodium falciparum merozoite micronemal protein, as a novel blood-stage vaccine candidate antigen. Infect Immun 2011, 79:4523-4532.
58. Proellocks N.I., Kovacevic S., Ferguson D.J., Kats L.M., Morahan B.J., Black C.G., et al. Plasmodium falciparum Pf34, a novel GPI-anchored rhoptry protein found in detergent-resistant microdomains. Int J Parasitol 2007, 37:1233-1241.
59. Arevalo-Pinzon G., Curtidor H., Vanegas M., Vizcaino C., Patarroyo M.A., Patarroyo M.E. Conserved high activity binding peptides from the Plasmodium falciparum Pf34 rhoptry protein inhibit merozoites in vitro invasion of red blood cells. Peptides 2010, 31:1987-1994.
60. Hinds L., Green J.L., Knuepfer E., Grainger M., Holder A.A. Novel putative glycosylphosphatidylinositol-anchored micronemal antigen of Plasmodium falciparum that binds to erythrocytes. Eukaryot Cell 2009, 8:1869-1879.